These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36527508)

  • 21. FRAX-based intervention thresholds in eight Eurasian countries: Armenia, Belarus, Georgia, Kazakhstan, the Kyrgyz Republic, Moldova, the Russian Federation, and Uzbekistan.
    Lesnyak O; Zakroyeva A; Babalyan V; Cazac V; Gabdulina G; Ismailov S; Lobanchenko O; Rudenka E; Tsagareli M; Johansson H; Harvey NC; McCloskey E; Kanis JA
    Arch Osteoporos; 2021 Jun; 16(1):87. PubMed ID: 34089424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A FRAX® model for the assessment of fracture probability in Belgium.
    Johansson H; Kanis JA; McCloskey EV; Odén A; Devogelaer JP; Kaufman JM; Neuprez A; Hiligsmann M; Bruyere O; Reginster JY
    Osteoporos Int; 2011 Feb; 22(2):453-61. PubMed ID: 20352409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Chakhtoura M; Leslie WD; McClung M; Cheung AM; Fuleihan GE
    Osteoporos Int; 2017 Jan; 28(1):127-137. PubMed ID: 27650643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted bone density testing for optimizing fracture prevention in Canada.
    Leslie WD; Morin SN; Lix LM; Binkley N
    Osteoporos Int; 2020 Jul; 31(7):1291-1297. PubMed ID: 32052071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Kanis JA; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; McCloskey EV
    Osteoporos Int; 2021 Oct; 32(10):1951-1960. PubMed ID: 33813622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.
    McCloskey E; Kanis JA; Johansson H; Harvey N; Odén A; Cooper A; Cooper C; Francis RM; Reid DM; Marsh D; Selby P; Thompson F; Hewitt S; Compston J
    Osteoporos Int; 2015 Aug; 26(8):2091-9. PubMed ID: 26077380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland.
    Lippuner K; Johansson H; Borgström F; Kanis JA; Rizzoli R
    Osteoporos Int; 2012 Nov; 23(11):2579-89. PubMed ID: 22222755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of bone mineral density in therapeutic decision-making using the Fracture Risk Assessment Tool (FRAX): a sub-study of the Taiwan OsteoPorosis Survey (TOPS).
    Chen JF; Yu SF; Hsu CY; Chiu WC; Wu CH; Lai HM; Chen YC; Su YJ; Chen JF; Cheng TT
    Arch Osteoporos; 2019 Oct; 14(1):101. PubMed ID: 31650396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
    Leslie WD; Lix LM; Binkley N
    Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FRAX-based fracture probabilities in South Africa.
    Johansson H; Dela SS; Cassim B; Paruk F; Brown SL; Conradie M; Harvey NC; Jordaan JD; Kalla AA; Liu E; Lorentzon M; Lukhele M; McCloskey EV; Mohamed O; Chutterpaul P; Vandenput L; Kanis JA
    Arch Osteoporos; 2021 Mar; 16(1):51. PubMed ID: 33649966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and application of FRAX in the management of osteoporosis in Ireland.
    McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
    Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of hip fracture in Brazil and the development of a FRAX model.
    Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
    Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
    Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
    Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka.
    Lekamwasam S; Chandran M; Subasinghe S
    Arch Osteoporos; 2019 Mar; 14(1):33. PubMed ID: 30850909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of FRAX and FRAX-Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry.
    Crandall CJ; Schousboe JT; Morin SN; Lix LM; Leslie W
    J Bone Miner Res; 2019 Aug; 34(8):1419-1427. PubMed ID: 30920022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An optimal intervention threshold of FRAX in postmenopausal Thai women.
    Sribenjalak D; Charoensri S; Pongchaiyakul C
    Arch Osteoporos; 2022 Jan; 17(1):21. PubMed ID: 35072805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
    Lippuner K
    Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women.
    Chandran M; Ganesan G; Tan KB; Reginster JY; Hiligsmann M
    Osteoporos Int; 2021 Jan; 32(1):133-144. PubMed ID: 32797250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold.
    Wang Y; Yu S; Hsu C; Tsai C; Cheng T
    Osteoporos Int; 2020 Mar; 31(3):475-483. PubMed ID: 31696272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.